Farasat Kazmi
Norwich, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer.
Journal: The Cochrane database of systematic reviews
Published: March 23, 2025
A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301).
Journal: Journal of experimental & clinical cancer research : CR
Published: November 09, 2023
Early phase antitumour clinical trials and palliative medicine.
Journal: BMJ supportive & palliative care
Published: July 14, 2023
The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 06, 2021
A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 10, 2020
Megavoltage Radiosensitization of Gold Nanoparticles on a Glioblastoma Cancer Cell Line Using a Clinical Platform.
Journal: International journal of molecular sciences
Published: October 26, 2019
Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis.
Journal: Journal of neuro-oncology
Published: October 08, 2018
Intensity-modulated radiotherapy for paranasal sinuses and base of skull tumors.
Journal: Oral oncology
Published: August 31, 2018
Early Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction in Asian Patients: A Single-Center Study.
Journal: World neurosurgery
Published: October 12, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026